U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX7671236: GSM4295057: siPAPα/γ_+_siARS2_Rep_2; Homo sapiens; RNA-Seq
1 ILLUMINA (Illumina HiSeq 2500) run: 36.6M spots, 2.8G bases, 1Gb downloads

Submitted by: NCBI (GEO)
Study: Kaposi's Sarcoma-associated herpesvirus fine-tunes the temporal expression of its genes manipulating a specific host RNA quality control pathway
show Abstracthide Abstract
Kaposi's Sarcoma-associated herpesvirus (KSHV) transcripts are subject to degradation by at least two host-mediated nuclear RNA decay pathways, PABPN1 and PAPa/?-mediated RNA decay (PPD) and an ARS2-dependent decay pathway. KSHV expresses the multifunctional protein ORF57, which increases viral transcripts stability by protecting them preferentially from ARS2-dependent decay. However, a subset of viral transcripts succumb to PPD even in the presence of ORF57, but the role of PPD during KSHV infection is not completely understood. We inactivated both decay pathways using siRNA and monitored their contribution to viral gene expression in the presence of ORF57 by RNA-Seq at 24 hours post induction (hpi). Inactivation of PPD, but not ARS2-mediated decay, results in aberrant accumulation of late transcripts, which are typically expressed at 48 hpi. PPD exerts its functions post-transcriptionally as the upregulation of late genes is independent of viral transactivation factors needed for their expression. Remarkably, at their proper time of expression, PPD inactivation has no effect on late transcripts. We further show that PPD evasion by late transcripts requires the host factor NRDE2. In conclusion, our studies show that KSHV uses PPD to fine-tune the temporal expression of its genes by preventing their premature accumulation. Overall design: RNA-seq experiment to compare the contribution of the host-mediated RNA decay pathways, PABPN1 and PAPa/?-mediated RNA decay (PPD) and an ARS2-dependent decay pathway to KSHV gene expression. PPD and ARS2-dependent decay pathways were inactivated by depleting iSLK WT cells of PAPa/? or ARS2, respectively, using siRNAs.
Sample: siPAPα/γ_+_siARS2_Rep_2
SAMN13981692 • SRS6098970 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: RNA was harvested using TRI reagent (Molecular Research Center, Inc.) according to the manufacturer's protocol. Total RNA was purified using Chloroform-isopropanol extraction. RNA samples were quantified using Nanodrop (Thermofisher) and RNA integrity was checked with Agilent TapeStation (Agilent Technologies, Palo Alto, CA, USA). RNA sequencing libraries were prepared using the KAPA Biosystems Stranded mRNA-Seq kit as per manufacturer's protocol. Briefly, mRNAs were first enriched with Oligod(T) beads. Enriched mRNAs were fragmented for 6 minutes at 94 °C in the presence of magnesium. First strand and second strand cDNA were subsequently synthesized. cDNA fragments were end repaired and adenylated at 3'ends, and universal adapter was ligated to cDNA fragments, followed by index addition (NEBNext multiplex Oligos for Illumina) and library enrichment with limited cycle PCR. The sequencing library was validated on the Agilent TapeStation (Agilent Technologies, Palo Alto, CA, USA), and quantified by using Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA).
Experiment attributes:
GEO Accession: GSM4295057
Links:
Runs: 1 run, 36.6M spots, 2.8G bases, 1Gb
Run# of Spots# of BasesSizePublished
SRR1101572536,570,8962.8G1Gb2020-04-28

ID:
10013675

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...